Cargando…
Efficacy of Convalescent Plasma to Treat Long-Standing COVID-19 in Patients with B-Cell Depletion
The use of antivirals, corticosteroids, and IL-6 inhibitors has been recommended by the WHO to treat COVID-19. CP has also been considered for severe and critical cases. Clinical trials on CP have shown contradictory results, but an increasing number of patients, including immunocompromised ones, ha...
Autores principales: | Tomisti, Luca, Angelotti, Francesca, Lenzi, Mirco, Amadori, Francesco, Sarteschi, Giovanni, Porcu, Anna, Capria, Anna-Lisa, Bertacca, Gloria, Lombardi, Stefania, Bianchini, Guido, Vincenti, Antonella, Cesta, Novella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302885/ https://www.ncbi.nlm.nih.gov/pubmed/37374049 http://dx.doi.org/10.3390/life13061266 |
Ejemplares similares
-
The Convalescent Plasma Craze! Where Does India Stand?
por: Priyadarsini, Arcot J., et al.
Publicado: (2021) -
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
por: Hueso, Thomas, et al.
Publicado: (2020) -
Llanfairfechan Convalescent Home
por: Butler, Anna M.
Publicado: (1887) -
Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
por: Ghelardi, Alessandro, et al.
Publicado: (2021) -
Heterogeneity in COVID‐19 Convalescent Plasma Clinical Trials
por: Müller‐Olling, Mirco, et al.
Publicado: (2021)